[et_pb_section fb_built=“1″ fullwidth=“on“ admin_label=“Section“ _builder_version=“4.2.1″ da_disable_devices=“off|off|off“ global_colors_info=“{}“ da_is_popup=“off“ da_exit_intent=“off“ da_has_close=“on“ da_alt_close=“off“ da_dark_close=“off“ da_not_modal=“on“ da_is_singular=“off“ da_with_loader=“off“ da_has_shadow=“on“][et_pb_fullwidth_slider use_text_overlay=“on“ text_overlay_color=“rgba(6,66,58,0.25)“ _builder_version=“4.11.3″ custom_padding=“83px||65px|||“ auto=“on“ auto_ignore_hover=“on“ global_colors_info=“{}“][et_pb_slide heading=“The HBV Cure FAQs“ use_bg_overlay=“off“ use_text_overlay=“on“ arrows_custom_color=“#2d788c“ dot_nav_custom_color=“#2d788c“ text_border_radius=“10px“ _builder_version=“4.11.3″ header_font=“|700|||||||“ header_text_align=“center“ body_text_align=“center“ body_font_size=“30px“ body_line_height=“1.3em“ background_enable_color=“off“ use_background_color_gradient=“on“ background_color_gradient_start=“rgba(0,0,0,0)“ background_color_gradient_end=“rgba(0,0,0,0)“ background_color_gradient_direction=“90deg“ background_color_gradient_overlays_image=“on“ background_image=“https:\/\/www.thervacb.eu\/wp-content\/uploads\/the-european-hbv-patient-registry-h.jpg“ background_enable_image=“on“ background_size=“initial“ text_orientation=“center“ custom_css_slide_container=“margin-left:55% !important;||width:50%;“ header_text_shadow_style=“preset1″ header_text_shadow_color=“#706f6f“ body_text_shadow_style=“preset1″ body_text_shadow_color=“#706f6f“ text_shadow_style=“preset1″ text_shadow_color=“#706f6f“ global_colors_info=“{}“ custom_css_slide_container_last_edited=“on|desktop“ custom_css_slide_container_tablet=“margin-left:auto ;||width:auto;“ sticky_transition=“on“]<\/p>\n
All you need to know to understand Hepatitis B cure research<\/p>\n
[\/et_pb_slide][\/et_pb_fullwidth_slider][\/et_pb_section][et_pb_section fb_built=“1″ admin_label=“Section“ _builder_version=“4.2.1″ custom_padding=“||1px|||“ da_disable_devices=“off|off|off“ global_colors_info=“{}“ da_is_popup=“off“ da_exit_intent=“off“ da_has_close=“on“ da_alt_close=“off“ da_dark_close=“off“ da_not_modal=“on“ da_is_singular=“off“ da_with_loader=“off“ da_has_shadow=“on“][et_pb_row module_id=“registry“ _builder_version=“4.9.0″ custom_padding=“||4px|||“ global_colors_info=“{}“][et_pb_column type=“4_4″ _builder_version=“4.3.4″ global_colors_info=“{}“][et_pb_text _builder_version=“4.11.3″ custom_margin=“||-8px|||“ global_colors_info=“{}“]<\/p>\n
Community webinars about Hepatits B cure (HBV) have been taking place the past few years with ICE-HBV and partners from around the world, aimed at empowering the community by equipping them with the knowledge needed to understand the HBV cure research that is taking place for their benefit. Based on this idea, a group of international organizations, expert institutions and research projects working in and around Hepatitis B, including TherVacB, are partnering to create an enduring tool for people to understand the cure research: the HBV Cure FAQs. This growing collection of short videos answers key questions to HBV cure research raised by people living with Hepatitis.<\/p>\n
<\/p>\n
[\/et_pb_text][et_pb_button button_url=“https:\/\/www.youtube.com\/playlist?list=PLsbUlOrWndnulXSUTr0doCOjsh-KkYXBW“ url_new_window=“on“ button_text=“Find all HBV Cure FAQ videos here. “ button_alignment=“center“ _builder_version=“4.11.3″ _module_preset=“default“ custom_button=“on“ button_text_color=“#FFFFFF“ button_bg_color=“#2D788C“ button_on_hover=“off“ global_colors_info=“{}“][\/et_pb_button][et_pb_text disabled_on=“on|on|on“ _builder_version=“4.11.3″ _module_preset=“default“ text_font_size=“20px“ disabled=“on“ global_colors_info=“{}“]<\/p>\n
[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=“1″ admin_label=“Section“ module_id=“whatdowe“ _builder_version=“4.11.3″ _module_preset=“default“ custom_margin=“0px||0px||false|false“ custom_padding=“0px||0px||false|false“ bottom_divider_color=“#1C9080″ da_popup_slug=“whatdowe“ da_disable_devices=“off|off|off“ global_colors_info=“{}“ da_is_popup=“off“ da_exit_intent=“off“ da_has_close=“on“ da_alt_close=“off“ da_dark_close=“off“ da_not_modal=“on“ da_is_singular=“off“ da_with_loader=“off“ da_has_shadow=“on“][et_pb_row module_id=“participate“ _builder_version=“4.11.3″ custom_margin=“||0px||false|false“ custom_padding=“||0px||false|false“ global_colors_info=“{}“][et_pb_column type=“4_4″ _builder_version=“4.3.4″ global_colors_info=“{}“][et_pb_text _builder_version=“4.11.3″ global_colors_info=“{}“]<\/p>\n
[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=“1_2,1_2″ use_custom_gutter=“on“ gutter_width=“2″ module_id=“participate“ _builder_version=“4.11.3″ custom_margin=“0px||||false|false“ custom_padding=“20px||||false|false“ global_colors_info=“{}“][et_pb_column type=“1_2″ _builder_version=“4.3.4″ global_colors_info=“{}“][et_pb_text _builder_version=“4.11.3″ _module_preset=“default“ custom_margin=“||0px||false|false“ custom_padding=“||0px||false|false“ global_colors_info=“{}“]<\/p>\n
People living with Hepatitis B in Nigeria, Africa and all over the world need a cure to have hope for the future, to be able to stop the struggling, stop the fear of transmitting the virus, to remove shame and stigma and be confident every day.<\/p>\n
[\/et_pb_text][et_pb_team_member name=“Answered by: Danjuma Adda, Nigeria “ position=“President, World Hepatitis Alliance “ image_url=“https:\/\/www.thervacb.eu\/wp-content\/uploads\/danjuma-adda-world-hepatitis-president.jpg“ module_class=“faqsperson“ _builder_version=“4.11.3″ _module_preset=“default“ global_colors_info=“{}“][\/et_pb_team_member][\/et_pb_column][et_pb_column type=“1_2″ _builder_version=“4.3.4″ global_colors_info=“{}“][et_pb_video src=“https:\/\/www.youtube.com\/watch?v=clW6Qk4-rIY“ _builder_version=“4.11.3″ _module_preset=“default“ global_colors_info=“{}“][\/et_pb_video][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=“1″ admin_label=“Section“ module_id=“whatdoyou“ _builder_version=“4.11.3″ _module_preset=“default“ custom_margin=“0px||0px||false|false“ custom_padding=“0px||0px||false|false“ bottom_divider_color=“#1C9080″ da_popup_slug=“whatdoyou“ da_disable_devices=“off|off|off“ global_colors_info=“{}“ da_is_popup=“off“ da_exit_intent=“off“ da_has_close=“on“ da_alt_close=“off“ da_dark_close=“off“ da_not_modal=“on“ da_is_singular=“off“ da_with_loader=“off“ da_has_shadow=“on“][et_pb_row module_id=“participate“ _builder_version=“4.11.3″ custom_margin=“||0px||false|false“ custom_padding=“||0px||false|false“ global_colors_info=“{}“][et_pb_column type=“4_4″ _builder_version=“4.3.4″ global_colors_info=“{}“][et_pb_text _builder_version=“4.11.3″ global_colors_info=“{}“]<\/p>\n
[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=“1_2,1_2″ use_custom_gutter=“on“ gutter_width=“2″ module_id=“participate“ _builder_version=“4.11.3″ custom_margin=“0px||||false|false“ custom_padding=“20px||||false|false“ global_colors_info=“{}“][et_pb_column type=“1_2″ _builder_version=“4.3.4″ global_colors_info=“{}“][et_pb_text _builder_version=“4.11.3″ _module_preset=“default“ custom_margin=“||0px||false|false“ custom_padding=“||0px||false|false“ global_colors_info=“{}“]<\/p>\n
The nature of the Hepatitis B virus is complex and can cause different kinds of infection. Thus, there are actually four levels of cure, each building on top of the last: level I partial cure, level II functional cure, level III complete cure and level IV sterilizing cure. <\/p>\n
[\/et_pb_text][et_pb_team_member name=“Answered by: Thomas Tu, Australia“ position=“Founder and Director, HepBCommunity.org; President, Australian Centre for Hepatitis Virology; Group Leader, Westmead Institute for Medical Research, University of Sydney, Australia “ image_url=“https:\/\/www.thervacb.eu\/wp-content\/uploads\/thomas-tu.jpg“ module_class=“faqsperson“ _builder_version=“4.11.3″ _module_preset=“default“ global_colors_info=“{}“][\/et_pb_team_member][\/et_pb_column][et_pb_column type=“1_2″ _builder_version=“4.3.4″ global_colors_info=“{}“][et_pb_video src=“https:\/\/www.youtube.com\/watch?v=m-AkX9PJzgY“ _builder_version=“4.11.3″ _module_preset=“default“ global_colors_info=“{}“][\/et_pb_video][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=“1″ admin_label=“Section“ module_id=“whatcoulda“ _builder_version=“4.11.3″ _module_preset=“default“ custom_margin=“0px||0px||false|false“ custom_padding=“0px||39px||false|false“ bottom_divider_color=“#1C9080″ da_popup_slug=“whatcoulda“ da_disable_devices=“off|off|off“ global_colors_info=“{}“ da_is_popup=“off“ da_exit_intent=“off“ da_has_close=“on“ da_alt_close=“off“ da_dark_close=“off“ da_not_modal=“on“ da_is_singular=“off“ da_with_loader=“off“ da_has_shadow=“on“][et_pb_row module_id=“participate“ _builder_version=“4.11.3″ custom_margin=“||0px||false|false“ custom_padding=“||0px||false|false“ global_colors_info=“{}“][et_pb_column type=“4_4″ _builder_version=“4.3.4″ global_colors_info=“{}“][et_pb_text _builder_version=“4.11.3″ global_colors_info=“{}“]<\/p>\n
[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=“1_2,1_2″ use_custom_gutter=“on“ module_id=“participate“ _builder_version=“4.11.3″ custom_margin=“0px||||false|false“ custom_padding=“20px||||false|false“ global_colors_info=“{}“][et_pb_column type=“1_2″ _builder_version=“4.3.4″ global_colors_info=“{}“][et_pb_text _builder_version=“4.11.3″ _module_preset=“default“ custom_margin=“||0px||false|false“ custom_padding=“||0px||false|false“ global_colors_info=“{}“]How are current therapies working and why is a functional cure of Hepatitis B so hard? Combination therapy with different drugs is the way to go to treat patients \u2026 but what tools do we think we will have to cure HBV? [\/et_pb_text][et_pb_team_member name=“Answered by: John Tavis, USA“ position=“Professor of Virology,St. Louis University School of Medicine, USA; Director, St. Louis University Drug Discovery Institute; Incoming Chair, International Coalition to Eliminate HBV ICE-HBV“ image_url=“https:\/\/www.thervacb.eu\/wp-content\/uploads\/john-tavis-professor-of-virology-and-director-of-the-drug-discovery-institute-at-saint-louis-university-school-of-medicine-1.jpg“ module_class=“faqsperson“ _builder_version=“4.11.3″ _module_preset=“default“ global_colors_info=“{}“][\/et_pb_team_member][\/et_pb_column][et_pb_column type=“1_2″ _builder_version=“4.3.4″ global_colors_info=“{}“][et_pb_video src=“https:\/\/www.youtube.com\/watch?v=kFl4lYt_5d4″ _builder_version=“4.11.3″ _module_preset=“default“ global_colors_info=“{}“][\/et_pb_video][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=“1″ admin_label=“Section“ module_id=“whatcoulda“ _builder_version=“4.11.3″ _module_preset=“default“ custom_margin=“0px||0px||false|false“ custom_padding=“0px||39px||false|false“ bottom_divider_color=“#1C9080″ da_popup_slug=“whatcoulda“ da_disable_devices=“off|off|off“ global_colors_info=“{}“ da_is_popup=“off“ da_exit_intent=“off“ da_has_close=“on“ da_alt_close=“off“ da_dark_close=“off“ da_not_modal=“on“ da_is_singular=“off“ da_with_loader=“off“ da_has_shadow=“on“][et_pb_row module_id=“participate“ _builder_version=“4.11.3″ custom_margin=“||0px||false|false“ custom_padding=“||0px||false|false“ global_colors_info=“{}“][et_pb_column type=“4_4″ _builder_version=“4.3.4″ global_colors_info=“{}“][et_pb_text _builder_version=“4.11.3″ global_colors_info=“{}“]<\/p>\n
[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=“1_2,1_2″ use_custom_gutter=“on“ module_id=“participate“ _builder_version=“4.11.3″ custom_margin=“0px||||false|false“ custom_padding=“20px||||false|false“ global_colors_info=“{}“][et_pb_column type=“1_2″ _builder_version=“4.3.4″ global_colors_info=“{}“][et_pb_text _builder_version=“4.11.3″ _module_preset=“default“ custom_margin=“||0px||false|false“ custom_padding=“||0px||false|false“ global_colors_info=“{}“]Why do we need clinical trials for HBV? And what does Phase 1, 2, and 3 mean? [\/et_pb_text][et_pb_team_member name=“Answered by: Philippa Matthews, UK“ position=“Infection Doctor and Clinical Group Leader at The Francis Crick Institute, UK“ module_class=“faqsperson“ _builder_version=“4.11.3″ _module_preset=“default“ global_colors_info=“{}“][\/et_pb_team_member][\/et_pb_column][et_pb_column type=“1_2″ _builder_version=“4.3.4″ global_colors_info=“{}“][et_pb_video src=“https:\/\/youtu.be\/NUhNaOAy1-8″ _builder_version=“4.11.3″ _module_preset=“default“ global_colors_info=“{}“][\/et_pb_video][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=“1″ admin_label=“Section“ module_id=“whatcoulda“ _builder_version=“4.11.3″ _module_preset=“default“ custom_margin=“0px||0px||false|false“ custom_padding=“0px||39px||false|false“ bottom_divider_color=“#1C9080″ da_popup_slug=“whatcoulda“ da_disable_devices=“off|off|off“ global_colors_info=“{}“ da_is_popup=“off“ da_exit_intent=“off“ da_has_close=“on“ da_alt_close=“off“ da_dark_close=“off“ da_not_modal=“on“ da_is_singular=“off“ da_with_loader=“off“ da_has_shadow=“on“][et_pb_row module_id=“participate“ _builder_version=“4.11.3″ custom_margin=“||0px||false|false“ custom_padding=“||0px||false|false“ global_colors_info=“{}“][et_pb_column type=“4_4″ _builder_version=“4.3.4″ global_colors_info=“{}“][et_pb_text _builder_version=“4.11.3″ global_colors_info=“{}“]<\/p>\n
[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=“1_2,1_2″ use_custom_gutter=“on“ module_id=“participate“ _builder_version=“4.11.3″ custom_margin=“0px||||false|false“ custom_padding=“20px||||false|false“ global_colors_info=“{}“][et_pb_column type=“1_2″ _builder_version=“4.3.4″ global_colors_info=“{}“][et_pb_text _builder_version=“4.11.3″ _module_preset=“default“ custom_margin=“||0px||false|false“ custom_padding=“||0px||false|false“ global_colors_info=“{}“]What do you think we are going to need to achieve an HBV cure? Anti-virals, immune therapies, or both? [\/et_pb_text][et_pb_team_member name=“Answered by: Ulrike Protzer, Germany“ position=“Institute of Virology, Technical University Munich \/ Helmholtz Munich, Germany – Coordinator of TherVacB“ image_url=“https:\/\/www.thervacb.eu\/wp-content\/uploads\/hmgu-ulrike-protzer.jpg“ module_class=“faqsperson“ _builder_version=“4.11.3″ _module_preset=“default“ global_colors_info=“{}“][\/et_pb_team_member][\/et_pb_column][et_pb_column type=“1_2″ _builder_version=“4.3.4″ global_colors_info=“{}“][et_pb_video src=“https:\/\/youtu.be\/55pdarnC1Xk“ _builder_version=“4.11.3″ _module_preset=“default“ global_colors_info=“{}“][\/et_pb_video][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=“1″ admin_label=“Section“ module_id=“whatcoulda“ _builder_version=“4.11.3″ _module_preset=“default“ custom_margin=“0px||0px||false|false“ custom_padding=“0px||39px||false|false“ bottom_divider_color=“#1C9080″ da_popup_slug=“whatcoulda“ da_disable_devices=“off|off|off“ global_colors_info=“{}“ da_is_popup=“off“ da_exit_intent=“off“ da_has_close=“on“ da_alt_close=“off“ da_dark_close=“off“ da_not_modal=“on“ da_is_singular=“off“ da_with_loader=“off“ da_has_shadow=“on“][et_pb_row module_id=“participate“ _builder_version=“4.11.3″ custom_margin=“||0px||false|false“ custom_padding=“||0px||false|false“ global_colors_info=“{}“][et_pb_column type=“4_4″ _builder_version=“4.3.4″ global_colors_info=“{}“][et_pb_text _builder_version=“4.11.3″ global_colors_info=“{}“]<\/p>\n
[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=“1_2,1_2″ use_custom_gutter=“on“ module_id=“participate“ _builder_version=“4.11.3″ custom_margin=“0px||||false|false“ custom_padding=“20px||||false|false“ global_colors_info=“{}“][et_pb_column type=“1_2″ _builder_version=“4.3.4″ global_colors_info=“{}“][et_pb_text _builder_version=“4.11.3″ _module_preset=“default“ custom_margin=“||0px||false|false“ custom_padding=“||0px||false|false“ global_colors_info=“{}“]Is a cure for HBV possible in the near future? Which therapeutic concepts are considered by the HBV cure research community in HBV treatment? Which are the main questions dealt with in clinical trials working to achieve functional HBV cure?[\/et_pb_text][et_pb_team_member name=“Answered by: Fabien Zoulim, France“ position=“ICE-HBV Chair, Medical Director of the Hepatology Department at the Hospices Civils de Lyon, and Scientific Director of the Department of Immunology and Virology of INSERM Unit 1052, France “ module_class=“faqsperson“ _builder_version=“4.11.3″ _module_preset=“default“ global_colors_info=“{}“][\/et_pb_team_member][\/et_pb_column][et_pb_column type=“1_2″ _builder_version=“4.3.4″ global_colors_info=“{}“][et_pb_video src=“https:\/\/www.youtube.com\/watch?v=6hhSJYSUkgg“ _builder_version=“4.11.3″ _module_preset=“default“ global_colors_info=“{}“][\/et_pb_video][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=“1″ admin_label=“Section“ module_id=“whatcoulda“ _builder_version=“4.11.3″ _module_preset=“default“ custom_margin=“0px||0px||false|false“ custom_padding=“0px||39px||false|false“ bottom_divider_color=“#1C9080″ da_popup_slug=“whatcoulda“ da_disable_devices=“off|off|off“ global_colors_info=“{}“ da_is_popup=“off“ da_exit_intent=“off“ da_has_close=“on“ da_alt_close=“off“ da_dark_close=“off“ da_not_modal=“on“ da_is_singular=“off“ da_with_loader=“off“ da_has_shadow=“on“][et_pb_row module_id=“participate“ _builder_version=“4.11.3″ custom_margin=“||0px||false|false“ custom_padding=“||0px||false|false“ global_colors_info=“{}“][et_pb_column type=“4_4″ _builder_version=“4.3.4″ global_colors_info=“{}“][et_pb_text _builder_version=“4.11.3″ global_colors_info=“{}“]<\/p>\n
[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=“1_2,1_2″ use_custom_gutter=“on“ module_id=“participate“ _builder_version=“4.11.3″ custom_margin=“0px||||false|false“ custom_padding=“20px||||false|false“ global_colors_info=“{}“][et_pb_column type=“1_2″ _builder_version=“4.3.4″ global_colors_info=“{}“][et_pb_text _builder_version=“4.11.3″ _module_preset=“default“ custom_margin=“||0px||false|false“ custom_padding=“||0px||false|false“ global_colors_info=“{}“]Watch to learn what clinical trials are, to hear more about their safety, and what patients should expect when participating in a clinical trial.[\/et_pb_text][et_pb_team_member name=“Answered by:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Laura Kaltenberg and Katharina Bartsch, Germany“ position=“Clinical Trial Project Managers at CTC North, Hamburg, Germany \u2013 TherVacB Clinical Trial Management“ image_url=“https:\/\/www.thervacb.eu\/wp-content\/uploads\/dr-katharina-bartsch.jpg“ module_class=“faqsperson“ _builder_version=“4.11.3″ _module_preset=“default“ custom_margin=“||-2px|||“ global_colors_info=“{}“][\/et_pb_team_member][et_pb_team_member name=“ “ position=“ “ image_url=“https:\/\/www.thervacb.eu\/wp-content\/uploads\/laura-kaltenberg.jpg“ module_class=“faqsperson“ _builder_version=“4.11.3″ _module_preset=“default“ global_colors_info=“{}“][\/et_pb_team_member][\/et_pb_column][et_pb_column type=“1_2″ _builder_version=“4.3.4″ global_colors_info=“{}“][et_pb_video src=“https:\/\/www.youtube.com\/watch?v=yQC2vgTpdZQ“ _builder_version=“4.11.3″ _module_preset=“default“ global_colors_info=“{}“][\/et_pb_video][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=“4.11.3″ _module_preset=“default“ global_colors_info=“{}“][et_pb_column type=“4_4″ _builder_version=“4.11.3″ _module_preset=“default“ global_colors_info=“{}“][et_pb_button button_url=“https:\/\/www.youtube.com\/playlist?list=PLsbUlOrWndnulXSUTr0doCOjsh-KkYXBW“ url_new_window=“on“ button_text=“Find all HBV Cure FAQ videos here“ _builder_version=“4.11.3″ _module_preset=“default“ global_colors_info=“{}“][\/et_pb_button][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"
All you need to know to understand Hepatitis B cure researchCollection of HBV Cure FAQ videos Community webinars about Hepatits B cure (HBV) have been taking place the past few years with ICE-HBV and partners from around the world, aimed at empowering the community by equipping them with the knowledge needed to understand the HBV […]<\/p>\n","protected":false},"author":3,"featured_media":0,"parent":7338,"menu_order":8,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":"","_links_to":"","_links_to_target":""},"class_list":["post-8891","page","type-page","status-publish","hentry"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.thervacb.eu\/de\/wp-json\/wp\/v2\/pages\/8891","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.thervacb.eu\/de\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.thervacb.eu\/de\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.thervacb.eu\/de\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.thervacb.eu\/de\/wp-json\/wp\/v2\/comments?post=8891"}],"version-history":[{"count":1,"href":"https:\/\/www.thervacb.eu\/de\/wp-json\/wp\/v2\/pages\/8891\/revisions"}],"predecessor-version":[{"id":11403,"href":"https:\/\/www.thervacb.eu\/de\/wp-json\/wp\/v2\/pages\/8891\/revisions\/11403"}],"up":[{"embeddable":true,"href":"https:\/\/www.thervacb.eu\/de\/wp-json\/wp\/v2\/pages\/7338"}],"wp:attachment":[{"href":"https:\/\/www.thervacb.eu\/de\/wp-json\/wp\/v2\/media?parent=8891"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}